Merck KGaA (GB:0O14)

Merck KGaA Stock Analysis & Ratings

GB:0O14 Stock Chart & Stats

Day’s Range€0 - €0
52-Week Range€153.10 - €231.40
Previous Close€160.81
Average Volume (3M)76.13K
Market CapN/A
Enterprise ValueN/A
P/E Ratio21.9
Next EarningsAug 04, 2022
Dividend Yield1.94 (1.15%)
Smart Score8



P/E Ratio Range

The price to earnings ratio. This is used by investors to assess a stock’s market price relative to its earnings.



What was Merck KGaA’s price range in the past 12 months?
Merck KGaA lowest stock price was €153.10 and its highest was €231.40 in the past 12 months.
    What is Merck KGaA’s market cap?
    Currently, no data Available
    What is Merck KGaA’s price target?
    The average price target for Merck KGaA is €214.25. This is based on 13 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
    The highest analyst price target is €250.00 ,the lowest forecast is €186.00. The average price target represents 33.23% Increase from the current price of €160.811.
      What do analysts say about Merck KGaA?
      Merck KGaA’s analyst rating consensus is a ‘Moderate Buy. This is based on the ratings of 13 Wall Streets Analysts.
        When is Merck KGaA’s upcoming earnings report date?
        Merck KGaA’s upcoming earnings report date is Aug 04, 2022 which is in 34 days.
          How were Merck KGaA’s earnings last quarter?
          Merck KGaA released its earnings results on May 12, 2022. The company reported €2.41 earnings per share for the quarter, beating the consensus estimate of €2.368 by €0.042.
            Is Merck KGaA overvalued?
            According to Wall Street analysts Merck KGaA’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
              Does Merck KGaA pay dividends?
              Merck KGaA pays a Annually dividend of €1.85 which represents an annual dividend yield of 1.15%. Merck KGaA’s last Annually dividend payment was on Apr 27, 2022. Merck KGaA’s upcoming ex-dividend date is Apr 25, 2022
                What is Merck KGaA’s EPS estimate?
                Merck KGaA’s EPS estimate is €2.48.
                  How many shares outstanding does Merck KGaA have?
                  Merck KGaA has 129,242,250 shares outstanding.
                    What happened to Merck KGaA’s price movement after its last earnings report?
                    Merck KGaA reported an EPS of €2.41 in its last earnings report, beating expectations of €2.368. Following the earnings report the stock price went down -4.276%.
                      Which hedge fund is a major shareholder of Merck KGaA?
                      Currently, no hedge funds are holding shares in GB:0O14


                      Merck KGaA Stock Analysis

                      The Merck KGaA Holdings stock analysis is based on the TipRanks Smart Score which is derived from 6 unique data sets including Analyst recommendations, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                      Learn more about TipRanks Smart Score

                      Company Description

                      Merck KGaA

                      Merck KGaA operates in three main segments: life sciences, performance materials, and healthcare. The life sciences segment provides laboratory consumables and instruments to researchers in academia and applied fields, including the biopharmaceutical industry. In its performance materials segment, the company offers specialty materials to manufacture a variety of products, such as semiconductors, flat-screen televisions, automobiles, and cosmetics. In the healthcare segment, Merck develops, manufactures, and sells branded pharmaceuticals with significant therapeutic concentrations in oncology, multiple sclerosis, and fertility. In 1995, the E. Merck KG family publicly sold part of the company, resulting in the current 30% public ownership of the firm.

                      Popular Stocks

                      What's Included in PREMIUM?
                      Make informed decisions based on Top Analysts' activity
                      Know what industry insiders are buying
                      Get actionable alerts from top Wall Street Analysts
                      Find out before anyone else which stock is going to shoot up
                      Get powerful stock screeners & detailed portfolio analysis